Omunis - About the company
Omunis is an unfunded company based in Clapiers (France), founded in 2014 by Pierre-Alain Rubbo. It operates as a Provider of in vitro diagnosis for infectious diseases. Omunis has not raised any funding yet. The company has 522 active competitors, including 117 funded and 72 that have exited. Its top competitors include companies like Adaptive Biotechnologies, MeMed and HaystackAnalytics.
Company Details
- Website
- omunis.com
- Social
- Email ID
- *****@omunis.com
Key Metrics
Founded Year
2014
Location
Clapiers, France
Stage
Unfunded
Ranked
347th among 522 active competitors
Similar Companies
Sign up to download Omunis' company profile
Omunis's funding and investors
Omunis has not raised any funding rounds yet.
Omunis' founders and board of directors
Founder? Claim ProfileThe founders of Omunis is Pierre-Alain Rubbo. Pierre-Alain Rubbo is the CEO of Omunis.
Here are the details of Omunis' key team members:
- Pierre-Alain Rubbo: Founder & CEO of Omunis.
View details of Omunis's Founder profiles and Board Members
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Omunis's Competitors and alternates
Top competitors of Omunis include Adaptive Biotechnologies, MeMed and HaystackAnalytics. Here is the list of Top 10 competitors of Omunis, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Adaptive Biotechnologies 2009, Seattle (United States), Public | Provider of clinical diagnostics, and drug discovery for immune diseases | $419M | 72/100 | |
2nd | Provider of machine learning based diagnostic solutions for infectious diseases | $163M | 68/100 | ||
3rd |  HaystackAnalytics 2018, Mumbai (India), Seed | Provider of genomics technology for personalized clinical decisions | $16.6M | 67/100 | |
4th | Neogen 1982, Lansing (United States), Acquired | Solutions for food and animal safety, diagnostics, and genomics | $700K | 67/100 | |
5th | Qiagen 1984, Venlo (Netherlands), Acquired | Provider of products and reagents for molecular diagnostic assays | - | 65/100 | |
6th | Inflammatix 2016, San Francisco (United States), Series E | Provider of diagnostic solutions for systemic infections | $191M | 64/100 | |
7th | Parse Biosciences 2018, Seattle (United States), Series C | Developer of RNA-sequencing solution-based transcriptome kit to analyze health data | $100M | 64/100 | |
8th |  Integrated DNA Technologies 1987, Coralville (United States), Acquired | Provider of oligonucleotide-based reagents and kits | - | 61/100 | |
9th | JUMPCODE Genomics 2016, Carlsbad (United States), Series B | Provider of a technology for depleting unwanted nucleic acid | $38.7M | 59/100 | |
10th |  Karius 2014, Redwood City (United States), Series C | Provider of diagnostics for identifying infectious diseases using microbial DNA | $315M | 58/100 | |
347th | Provider of in vitro diagnosis for infectious diseases | - | - | 24/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Omunis's competitors? Click here to see the top ones
Omunis's Investments and acquisitions
Omunis has made no investments or acquisitions yet.
Are you a Founder ?
FAQs about Omunis
Explore our recently published companies
- Answers to ACS - Chicago based, 2013 founded, Unfunded company
- Antivirus Americas - Pembroke Pines based, 2013 founded, Unfunded company
- Antikeo - France based, 2020 founded, Unfunded company
- WinField United - Austin based, 2016 founded, Unfunded company
- Anderson Business Products - Minneapolis based, 1983 founded, Unfunded company
- Amy Green Cleaning - Sautee Nacoochee based, 2001 founded, Unfunded company
